Effect of Oral Misoprostol After Second‐Trimester Delivery: A Randomized, Blinded Study

Leader, Jeanette; Bujnovsky, Marcella; Carlan, S. J.; More

Obstetrics & Gynecology . 100(4):689-694, October 2002.

Prostaglandin E2 Gel Versus Misoprostol for Cervical Ripening in Patients With Premature Rupture of Membranes After 34 Weeks

Frohn, W. Eric; Simmons, Stephanie; Carlan, S. J.

Obstetrics & Gynecology . 99(2):206-210, February 2002.

Sulindac to Prevent Recurrent Preterm Labor: A Randomized Controlled Trial

Humphrey, Rachel G.; Bartfield, Michael C.; Carlan, S. J.; More

Obstetrics & Gynecology . 98(4):555-562, October 2001.

Safety and Efficacy of Misoprostol Orally and Vaginally: A Randomized Trial

Carlan, S. J.; Bouldin, Sheila; Blust, Danielle; More

Obstetrics & Gynecology . 98(1):107-112, July 2001.

Randomized Trial of Endovaginal Ultrasound in Preterm Premature Rupture of Membranes.

CARLAN, S. J.; RICHMOND, L. B.; O'BRIEN, W. F.

Obstetrics & Gynecology . 89(3):458-461, March 1997.

Effect of Intramuscular 15-Methyl Prostaglandin F2[alpha] After Second-Trimester Delivery.

CARLAN, S. J.; GUSHWA, J. P.; O'BRIEN, W. F.; More

Obstetrics & Gynecology . 89(1):5-9, January 1997.